199 Baricitinib in patients with systemic lupus erythematosus: results from a phase 2, randomized, double-blind, placebo-controlled study

Maria E Silk; Daniel J Wallace; Richard A Furie; Yoshiya Tanaka; Kenneth C Kalunian; Marta Mosca; Michelle Petri; Thomas Dörner; Mario H Cardiel; Ian N Bruce; Elisa Gomez; Amy M DeLozier; Jonathan M Janes; Matthew D Linnik; Stephanie de Bono; Robert W Hoffman

doi:10.1136/lupus-2019-lsm.199

Article info

Abstracts

199 Baricitinib in patients with systemic lupus erythematosus: results from a phase 2, randomized, double-blind, placebo-controlled study

Free

Authors

Maria E Silk 1Eli Lilly and Company PubMed articles Google scholar articles
Daniel J Wallace 2Cedars-Sinai Medical Center/David Geffen School of Medicine University of California Los Angeles PubMed articles Google scholar articles
Richard A Furie 3Zucker School of Medicine at Hofstra/Northwell PubMed articles Google scholar articles
Yoshiya Tanaka 4University of Occupational and Environmental Health, Japan PubMed articles Google scholar articles
Kenneth C Kalunian 5University of California at San Diego School of Medicine PubMed articles Google scholar articles
Marta Mosca 6University of Pisa PubMed articles Google scholar articles
Michelle Petri 7Johns Hopkins University School of Medicine PubMed articles Google scholar articles
Thomas Dörner 8Charite Universitätsmedizin Berlin and Deutsches Rheuma-Forschungszentrum (DRFZ) PubMed articles Google scholar articles
Mario H Cardiel 9Centro de Investigación Clínica de Morelia SC PubMed articles Google scholar articles
Ian N Bruce 10The University of Manchester, Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Faculty of Biology Medicine and Health PubMed articles Google scholar articles
Elisa Gomez 1Eli Lilly and Company PubMed articles Google scholar articles
Amy M DeLozier 1Eli Lilly and Company PubMed articles Google scholar articles
Jonathan M Janes 1Eli Lilly and Company PubMed articles Google scholar articles
Matthew D Linnik 1Eli Lilly and Company PubMed articles Google scholar articles
Stephanie de Bono 1Eli Lilly and Company PubMed articles Google scholar articles
Robert W Hoffman 1Eli Lilly and Company PubMed articles Google scholar articles

Citation

Silk ME, Wallace DJ, Furie RA, et al

199 Baricitinib in patients with systemic lupus erythematosus: results from a phase 2, randomized, double-blind, placebo-controlled study

Lupus Science & Medicine 2019;6:doi: 10.1136/lupus-2019-lsm.199

Publication history

First published April 5, 2019.

Online issue publication

May 13, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password